XDUK:F:F-Xtrackers FTSE 100 UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 14.978

Change

-0.14 (-0.95)%

Market Cap

USD 0.05B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.35 (+1.32%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

N/A

USD 112.00B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.86 (+0.15%)

USD 98.90B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.70 (+1.29%)

USD 92.14B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.35B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.19 (+1.28%)

USD 53.27B
VUSA:F Vanguard Funds Public Limited ..

+0.31 (+0.30%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.38 (+0.37%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.01 (-0.14%)

USD 40.47B
0ZC:F Zscaler Inc

+2.84 (+1.65%)

USD 37.92B

ETFs Containing XDUK:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.35% 67% D+ 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.35% 67% D+ 67% D+
Trailing 12 Months  
Capital Gain 21.52% 57% F 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.52% 57% F 62% D
Trailing 5 Years  
Capital Gain 39.75% 64% D 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.75% 64% D 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.72% 75% C 70% C-
Dividend Return 10.72% 73% C 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.87% 52% F 82% B
Risk Adjusted Return 83.32% 88% B+ 91% A-
Market Capitalization 0.05B 19% F 24% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.